Related Experiment Video
Updated: Nov 12, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Poor Myocardial Compaction in a Patient with Recessive MYL2 Myopathy
Ayaka Monoi Tamamitsu1, Yu Nakagama1,2, Yukako Domoto3
1Department of Pediatrics, Graduate School of Medicine, The University of Tokyo.
Abstract:
Recessive mutations in the Myosin regulatory light chain 2 (MYL2) gene are the cause of an infantile-onset myopathy, associated with fatal myocardial disease of variable macromorphology. We here present the first Japanese family affected with recessive MYL2 myopathy. Affected siblings manifested typical features and the proband's autopsy findings were compatible with the diagnosis of noncompaction cardiomyopathy. The rapidly progressive clinical course of this recessive MYL2 cardiomyopathy highlights the crucial role of c-terminal tails in MYL2 protein in maintaining cardiac morphology and function.
Insights
Recessive mutations in the Myosin regulatory light chain 2 (MYL2) gene cause infantile myopathy and fatal heart disease. This study details the first Japanese family with MYL2 myopathy, emphasizing the protein
Area of Science:
- Genetics and Molecular Biology
- Cardiology
- Neurology
Background:
- Recessive mutations in the Myosin regulatory light chain 2 (MYL2) gene are linked to infantile-onset myopathy.
- This condition is often associated with fatal myocardial disease, presenting with variable macromorphology.
Observation:
- The study reports the first Japanese family diagnosed with recessive MYL2 myopathy.
- Affected siblings exhibited characteristic clinical features of the disease.
Findings:
- Autopsy findings of the proband were consistent with noncompaction cardiomyopathy.
- The rapid progression of this recessive MYL2 cardiomyopathy underscores the importance of the MYL2 protein's c-terminal tails.
Implications:
- The c-terminal tails of MYL2 are crucial for maintaining normal cardiac morphology and function.
- Understanding these mutations provides insights into genetic cardiomyopathies and potential therapeutic targets.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis I: Introduction